Bear Markets May Feel Frightening, But Here's How You Can Come Out Ahead

The article argues that investors should remain invested through bear markets, citing roughly 27 S&P 500 bear markets since 1928 versus 28 bull markets. Average bear markets have lasted 289 days (9.6 months), compared with 988 days (2.7 years) for bull markets, supporting dollar-cost averaging and avoiding panic selling. It highlights defensive consumer-staples and healthcare exposure, including Procter & Gamble and Johnson & Johnson, as potential bear-resilient dividend holdings.

Analysis

This is primarily retail-flow content rather than a new fundamental input; the direct signal for PG and JNJ is negligible. Its relevance is as a positioning tell: defensive-sector inflows tend to arrive after volatility has already repriced cyclicals, leaving Staples Select Sector SPDR (XLP) and Health Care Select Sector SPDR (XLV) vulnerable to valuation-driven underperformance if growth or real yields stabilize. PG's premium multiple requires continued organic-sales resilience and gross-margin delivery; JNJ's diversification makes it a cleaner recession hedge but litigation and medtech procedure sensitivity remain company-specific offsets.

Over the next 1-3 months, the more actionable question is whether a risk-off episode is earnings-led or rate-led. In an earnings recession, PG/JNJ can sustain relative outperformance through lower revenue beta and capital-return support; in a duration shock, their bond-proxy characteristics can compress multiples despite stable results. A sustained move higher in 10-year real yields, or a broad risk rally led by semiconductors, would likely reverse defensive leadership quickly.

Contrarianly, indiscriminate 'stay invested' messaging can reinforce passive buying into broad-cap-weighted indexes, increasing concentration rather than diversification. If volatility rises while NVDA holds leadership, market participants should distinguish a narrow AI-capex correction from a genuine demand recession; the former argues against paying up for defensives and favors retaining selective secular growth exposure. There is no standalone trade catalyst in the article.

Key Decisions for Investors

• No directional trade solely on this item; monitor XLP/SPY and XLV/SPY relative strength for 2-4 weeks as confirmation of genuine defensive rotation rather than retail-driven flow.
• If recession indicators deteriorate and PG reports organic growth above guidance with stable gross margin, consider long PG / short XLY for a 3-6 month defensive-spread expression; exit if PG organic-sales guidance is cut or XLY/SPY breadth materially improves.
• Prefer JNJ over PG for a 6-12 month defensive allocation only if litigation reserve visibility improves and medtech growth remains intact; use a 5-7% relative-underperformance stop versus XLV given event-risk around legal developments.
• If 10-year real yields rise materially while XLP trades at an expanding premium to SPY, reduce defensive exposure or consider a tactical short XLP versus SPY; stable earnings do not protect against duration-driven multiple compression.